1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.84%
Revenue growth 1.25-1.5x FSLR's 35.61%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
74.47%
Gross profit growth above 1.5x FSLR's 38.70%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
122.62%
EBIT growth above 1.5x FSLR's 52.63%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
203.70%
Operating income growth above 1.5x FSLR's 52.63%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
159.66%
Net income growth above 1.5x FSLR's 49.45%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
160.00%
EPS growth above 1.5x FSLR's 47.46%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
164.29%
Diluted EPS growth above 1.5x FSLR's 49.12%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.57%
Share count expansion well above FSLR's 1.03%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.45%
Diluted share count expanding well above FSLR's 0.49%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
143.24%
Positive OCF growth while FSLR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
88.10%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
417.66%
10Y revenue/share CAGR under 50% of FSLR's 4171.44%. Michael Burry would suspect a lasting competitive disadvantage.
417.66%
5Y revenue/share CAGR under 50% of FSLR's 4171.44%. Michael Burry would suspect a significant competitive gap or product weakness.
417.66%
3Y revenue/share CAGR under 50% of FSLR's 1309.57%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-65.03%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-65.03%
Negative 5Y OCF/share CAGR while FSLR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-65.03%
Negative 3Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
209.07%
Below 50% of FSLR's 998.61%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
209.07%
Below 50% of FSLR's 998.61%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
209.07%
Below 50% of FSLR's 16944.33%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.49%
AR growth is negative/stable vs. FSLR's 168.92%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
6.41%
Inventory shrinking or stable vs. FSLR's 82.55%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
8.04%
Asset growth at 50-75% of FSLR's 13.40%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
6.78%
Similar to FSLR's 7.52%. Walter Schloss finds parallel capital usage or profit distribution strategies.
No Data
No Data available this quarter, please select a different quarter.
3.68%
R&D dropping or stable vs. FSLR's 62.29%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
27.62%
SG&A declining or stable vs. FSLR's 68.28%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.